You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
IN VITRO DRUG SENSITIVITY TESTING OF MARROW METASTASES
SBC: BIS LABORATORIES Topic: N/AHUMAN TUMOR CLONOGENIC ASSAYS (HTCA'S) ARE USED TO TEST TUMOR SPECIMENT IN VITRO AGAINST CHEMOTHERAPEUTIC DRUGS. CURRENTLY, USE OF HTCA'S IS LIMITED TO TUMOR SPECIMENS OBTAINED AT DIAGNOSIS OR AT OVERT RELAPSE. AN IDEAL SITUATION WOULD BE TO TEST METASTATIC CELLS PRIOR TO RELAPSE BEFORE DRUG RESISTANCE IS A FACTOR. THIS SITUATION IS FEASIBLE BY OBTAINING SMALL NUMBERS OF TUMOR CELLS FROM THE BONE ...
SBIR Phase II 1996 Department of Health and Human Services -
NEXT GENERATION SOFTWARE FOR GROUP SEQUENTIAL ANALYSIS
SBC: INSIGHTFUL CORPORATION Topic: N/AN/A
SBIR Phase II 1997 Department of Health and Human Services -
LIPOSOMES FOR DELIVERY OF DRUGS TO HAIR-FOLLICLE CELLS
SBC: ANTICANCER, INC. Topic: N/ATHERE IS A NEED TO STIMULATE HAIR GROWTH FOR VARIOUS CONDITIONS OF ALOPECIA. IT IS ASSERTED THAT TO ACHIEVE HAIR GROWTH STIMULATION, BIOLOGICALLY ACTIVE COMPOUNDS MUST BE DELIVERED INSIDE HAIR FOLLICLE CELLS, AND THAT THE OPTIMAL WAY TO IDENTIFY ACTIVE COMPOUNDS AND METHODS OF THEIR DELIVERY IS TO USE AN IN VITRO SYSTEM. ACTIVE COMPOUNDS IN PRINCIPLE COULD BE ALSO USED TO CAUSE DESIRED IN HAIR COL ...
SBIR Phase II 1996 Department of Health and Human Services -
Semiautomatic, Quantitative Analysis of Funds
SBC: APPLIED SCIENCES LABORATORY, INC. Topic: N/AN/A
SBIR Phase II 1996 Department of Health and Human Services -
NEW X RAY TUBE FOR CT SCANNERS
SBC: AXR, INC. Topic: N/AN/A
SBIR Phase II 1997 Department of Health and Human Services -
Accurate Characterization of Composite Strength Through Empirical and Progressive Damage Methods
SBC: Biosearch Technologies, Inc Topic: N/AN/A
SBIR Phase II 1996 Department of Health and Human Services -
COMBINATORIAL CHEMISTRY ON ASPECT SUPPORTS
SBC: Biosearch Technologies, Inc Topic: N/AN/A
SBIR Phase II 1997 Department of Health and Human Services -
Human Iduronidase Hurler syndrome expression in plant
SBC: CROPTECH CORPORATION Topic: N/AN/A
SBIR Phase II 1997 Department of Health and Human Services -
Human Monoclonal Antibody to Respiratory Syncytial Virus
SBC: IDEC PHARMACEUTICALS CORPORATION Topic: N/APassive immunotherapy has been shown to be an effective method for controlling RSV infection. The virus envelope fusion (F protein) represents an ideal target for passive immunotherapy because antibodies to this protein typically bind to and neutralize both of the two clinical subgroups of this virus, A and B. In addition, antibodies to the F protein have been shown to provide protection in animal ...
SBIR Phase II 1996 Department of Health and Human Services -
Improved Beta"-Alumina Fabrication Using Rapid Plasma Sintering
SBC: INSIGHTFUL CORPORATION Topic: N/AN/A
SBIR Phase II 1996 Department of Health and Human Services